Accuracy of axillary MR imaging in treated breast cancer for distinguishing between recurrent tumour and treatment effects: Does intravenous Gd-DTPA enhancement help in cases of diagnostic dilemma?
Aj. Bradley et al., Accuracy of axillary MR imaging in treated breast cancer for distinguishing between recurrent tumour and treatment effects: Does intravenous Gd-DTPA enhancement help in cases of diagnostic dilemma?, CLIN RADIOL, 55(12), 2000, pp. 921-928
AIM: To evaluate the sensitivity and specificity of axillary magnetic reson
ance imaging (MRI) in symptomatic patients, who had previously been treated
for breast cancer, compared with clinical outcome after a minimum of 1 yea
r.
METHODS: One hundred and five patients underwent axillary MRI examinations
and were diagnosed as axillary tumour, metastatic tumour, treatment effect
or normal.
RESULTS: At MRI, 48 patients had axillary tumour, 51 had metastatic tumour
(37 had both), 27 had treatment effect and 22 were normal. At outcome (medi
an follow-up, 484 days), 54 patients were positive for axillary tumour, 59
for metastatic disease (40 had both), 21 had treatment effect alone and 18
were clear. Magnetic resonance imaging showed 89% sensitivity, 100% specifi
city and 91% accuracy for recurrent axillary tumour, and 85% sensitivity, 9
8% specificity and 90% accuracy for metastatic tumour. Soft tissue plaques
were the commonest axillary disease pattern seen (37). Small volume soft ti
ssue plaques gave the most diagnostic difficulty. Non-dynamic enhancement w
ith intravenous Gadopentetate dimeglumine (Gd-DTPA) in a subset of 34 patie
nts improved sensitivity for axillary tumour from 40 to 74%, and improved d
iagnostic confidence in 11 patients (32%). Magnetic resonance imaging had a
positive management impact leading to treatment alteration in 45 patients,
43 of whom had recurrent axillary and/or metastatic tumour.
CONCLUSIONS: Tumour plaques were the commonest pattern of recurrent axillar
y disease, Forty-eight percent of the patients had metastatic deposits iden
tified by MRI. Magnetic resonance imaging had excellent specificity (100%)
and good sensitivity (89%) for recurrent axillary tumour compared with outc
ome at 1 year, which was improved by non-dynamic administration of Gd-DTPA
in 32% of the subset who received it. Bradley, A. J. et al. (2000). Clinica
l Radiology 55, 921-928. (C) 2000 The Royal College of Radiologists.